Wednesday, January 15, 2025

Yearly Archives: 2016

Bernie Sanders Admits He Wants Trump to Win GOP Candidacy

"I want Trump to win the Republican nomination – and I would love the opportunity to run against him. I think we would win by a lot.”

The Sanders Sensation

Bernie’s people-powered movement has already shattered one of the Democratic establishment’s holy myths.

Elizabeth Warren Recalls a Time When Big Donors May Have Changed Hillary’s Vote

With our corrupted campaign finance system, elected officials design policy with special-interest money in mind.

Army of Lobbyists Push LNG Exports, Methane Hydrates, Coal in Senate Energy Bill

A newly introduced bill includes provisions that would expedite the liquefied natural gas (LNG) export permitting process, heap subsidies on coal technology, and fund research geared toward discovering a way to tap into methane hydrate reserves.

America’s New Vietnam in the Middle East

And if anyone says the analogy between Vietnam and the current conflict is debatable, that’s just the point. Rather than a rush to yet more war, it’s time to have a real national debate on the subject.

Wall Street CEO Calls Bernie Sanders ‘Dangerous’

The CEO of Goldman Sachs says that not only is Bernie Sanders a "liability" but that his campaign has "the potential to be a dangerous moment."

Exasperated by Netanyahu, France Prepares to Recognize Palestinian State

The French parliament urged recognition of Palestine in a vote in 2014. Sweden has recognized Palestine and a number of other European countries have raised the Palestinian mission in their capitals to the rank of full embassy.

The Trump Show is Ending. Time To Look At What The Real Candidates Say.

The Trump fog is lifting. Time to start looking.

San Francisco Clears Out Homeless Ahead Of The Super Bowl

Millions of fans will descend on the city, but the homeless have been moved elsewhere.

Emails Reveal Martin Shkreli Raised Drug Prices Purely For Profit

"These new documents provide a rare, inside look at the motivations and tactics of drug company executives."